PulseSight Therapeutics
Signal active
Organization
Contact Information
Overview
PulseSight is an ophthalmology drug development company creating novel, non-viral gene therapies with minimally invasive delivery technology to address the unmet need for treatments against severe retinal diseases leading to blindness.
About
Industries
Biotechnology, Medical, Therapeutics
Founded
Invalid date
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
PulseSight Therapeutics headquartered in Europe, operates in the Biotechnology, Medical, Therapeutics sector. With a team of 11-50 employees, PulseSight Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - PulseSight Therapeutics, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
3
Lead Investors
0
Total Funding Amount
$0
Details
1
PulseSight Therapeutics has raised a total of $0 in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Seed |
Investors
PulseSight Therapeutics is funded by 7 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| +ND Capital | - | FUNDING ROUND - +ND Capital | undefined |
| Dominik Escher | - | FUNDING ROUND - Dominik Escher | undefined |
| PulseSight Therapeutics | - | FUNDING ROUND - PulseSight Therapeutics | undefined |
| Pureos Bioventures | - | FUNDING ROUND - Pureos Bioventures | undefined |
Recent Activity
There is no recent news or activity for this profile.